Skip to main content
SpringerLink
Log in

Fibromyalgia Syndrome and Sleep

  • Chapter
  • First Online:
Fibromyalgia Syndrome

Abstract

Almost totality of fibromyalgia patients complain of disturbed sleep, but to date, this topic is at the centre of many controversies. First of all, subjective sleep complaints can be found in all patients, but not all studies observed altered objective parameters when investigating sleep using polysomnography; therefore, currently, no disease-specific sleep alterations have been found. Secondly, sleep disturbances correlate with many fibromyalgia symptoms, and it is now known that the relationship between sleep and pain is bidirectional, but it is still not clear why the sleep of fibromyalgia patients is so disrupted. Putative mechanisms include alterations in the hormonal, neurotransmitter and immune systems, and in the autonomic nervous system. There are also no interventions that are both safe and effective for improving sleep in fibromyalgia patients; hence, treatment must be multidimensional and take into account the multiple causative factors and the frequent fibromyalgia comorbidities. First, it is necessary to adopt behavioural changes, including sleep hygiene practices and regular exercise; secondly, some pharmacological treatments can be tried, such as pregabalin, amitriptyline and very low dose cyclobenzaprine, which are frequently used to treat pain and sleep disturbances in fibromyalgia patients, whilst duloxetine and milnacipran are less effective on sleep. New promising drugs are sodium oxybate, cannabis and cannabinoids. The high frequency of sleep alterations and their complex relationship with other manifestations in fibromyalgia mean that physicians should specifically address them, in order to have a positive effect on patients’ quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Askitopoulou H. Sleep and dreams: from myth to medicine in ancient Greece. J Anesth Hist. 2015;1:70–5. http://www.anesthesiahistoryjournal.org/article/S2352452915200102/fulltext [Accessed July 9, 2020

    Article  Google Scholar 

  2. Irwin MR. Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol. 2015;66:143–72.

    Article  PubMed  Google Scholar 

  3. Saper CB, Cano G, Scammell TE. Homeostatic, circadian, and emotional regulation of sleep. J Comp Neurol, J Comp Neurol. 2005;493:92–8.

    Google Scholar 

  4. Dunmyre JR, Mashour GA, Booth V. Coupled flip-flop model for REM sleep regulation in the rat. PLoS One. 2014;9:e94481.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Carley DW, Farabi SS. Physiology of sleep. Diabetes Spectr. 2016;29:5–9.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lucey BP, Mcleland JS, Toedebusch CD, Boyd J, Morris JC, Landsness EC, Yamada K, Holtzman DM. Comparison of a single-channel EEG sleep study to polysomnography. J Sleep Res. 2016;25:625–35.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Acebo C, LeBourgeois MK. Actigraphy. Respir Care Clin N Am. 2006;12:23–30. https://pubmed.ncbi.nlm.nih.gov/16530645/ [Accessed July 9, 2020

    PubMed  Google Scholar 

  8. Littner M, Hirshkowitz M, Kramer M, Kapen S, McDowell Anderson W, Bailey D, Berry RB, Davila D, Johnson S, Kushida C, Loube DI, Wise M, Tucker WB. Practice parameters for using polysomnography to evaluate insomnia: an update. Sleep. 2003;26:754–60.

    Article  PubMed  Google Scholar 

  9. Morin CM, Belleville G, Bélanger L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34:601–8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Cole JC, Motivala SJ, Buysse DJ, Oxman MN, Levin MJ, Irwin MR. Validation of a 3-factor scoring model for the Pittsburgh Sleep Quality Index in older adults. Sleep. 2006;29:112–6.

    Article  PubMed  Google Scholar 

  11. Okun ML. Biological consequences of disturbed sleep: Important mediators of health? Jpn Psychol Res. 2011;53:163–76.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Andrade A, Vilarino GT, Sieczkowska SM, Coimbra DR, Bevilacqua GG, Steffens R de AK. The relationship between sleep quality and fibromyalgia symptoms. J Health Psychol 2018:135910531775161.

    Google Scholar 

  13. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8:27.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Liedberg GM, Björk M, Börsbo B. Self-reported nonrestorative sleep in fibromyalgia - relationship to impairments of body functions, personal function factors, and quality of life. J Pain Res. 2015;8:499–505.

    PubMed  PubMed Central  Google Scholar 

  15. Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fibromyalgia syndrome: Relationship to pain and depression. Arthritis Care Res. 2008;59:961–7.

    Article  Google Scholar 

  16. Wagner JS, Dibonaventura MD, Chandran AB, Cappelleri JC. The association of sleep difficulties with health-related quality of life among patients with fibromyalgia. BMC Musculoskelet Disord. 2012;13:199. Available at: /pmc/articles/PMC3526442/?report=abstract [Accessed July 14, 2020].

    Google Scholar 

  17. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg D, Tugwell P, Campbell SM, Abeles M, Clark P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160–72.

    Article  CAS  PubMed  Google Scholar 

  18. Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, Martin SA, Morea J, Simon L, Strand CV, Williams DA. Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol. 2009;36:2318–2329.

    Google Scholar 

  19. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62:600–10.

    Article  Google Scholar 

  20. Kleinman L, Mannix S, Arnold LM, Burbridge C, Howard K, McQuarrie K, Pitman V, Resnick M, Roth T, Symonds T. Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary. Health Qual Life Outcomes 2014;12.

    Google Scholar 

  21. Theadom A, Cropley M. “This constant being woken up is the worst thing” – experiences of sleep in fibromyalgia syndrome. Disabil Rehabil. 2010;32:1939–47.

    Article  PubMed  Google Scholar 

  22. Wu YL, Chang LY, Lee HC, Fang SC, Tsai PS. Sleep disturbances in fibromyalgia: a meta-analysis of case-control studies. J Psychosom Res. 2017;96:89–97.

    Article  PubMed  Google Scholar 

  23. Fang SC, Wu YL, Chen SC, Teng HW, Tsai PS. Subjective sleep quality as a mediator in the relationship between pain severity and sustained attention performance in patients with fibromyalgia. J Sleep Res. 2019;28

    Google Scholar 

  24. Côté KA, Moldofsky H. Sleep, daytime symptoms, and cognitive performance in patients with fibromyalgia. J Rheumatol. 1997;24:2014–23.

    Google Scholar 

  25. Correa-Rodríguez M, El Mansouri-Yachou J, Casas-Barragán A, Molina F, Rueda-Medina B, Aguilar-Ferrandiz ME. The association of body mass index and body composition with pain, disease activity, fatigue, sleep and anxiety in women with fibromyalgia. Nutrients. 2019;11

    Google Scholar 

  26. Wagner JS, Chandran A, Dibonaventura M, Cappelleri JC. The costs associated with sleep symptoms among patients with fibromyalgia. Expert Rev Pharmacoeconom Outcomes Res. 2013;13:131–9.

    Article  Google Scholar 

  27. Segura-Jiménez V, Camiletti-Moirón D, Munguía-Izquierdo D, Álvarez-Gallardo IC, Ruiz JR, Ortega FB, Delgado-Fernández M. Agreement between self-reported sleep patterns and actigraphy in fibromyalgia and healthy women. Clin Exp Rheumatol. 2015;33:S58–67.

    PubMed  Google Scholar 

  28. Branco J, Atalaia A, Paiva T. Sleep cycles and alpha-delta sleep in fibromyalgia syndrome. J Rheumatol. 1994;21:1113–7.

    CAS  PubMed  Google Scholar 

  29. Drewes AM, Nielsen KD, Taagholt SJ, Svendsen L, Bjerregaard K, Gade J. Sleep intensity in fibromyalgia: focus on the microstructure of the sleep process. Br J Rheumatol. 1995;34:629–35.

    Article  CAS  PubMed  Google Scholar 

  30. Sergi M, Rizzi M, Braghiroli A, Sarzi Puttini P, Greco M, Cazzola M, Andreoli A. Periodic breathing during sleep in patients affected by fibromyalgia syndrome. Eur Respir J. 1999;14:203–8.

    Article  CAS  PubMed  Google Scholar 

  31. Diaz-Piedra C, Di Stasi LL, Baldwin CM, Buela-Casal G, Catena A. Sleep disturbances of adult women suffering from fibromyalgia: a systematic review of observational studies. Sleep Med Rev. 2015;21:86–99.

    Article  PubMed  Google Scholar 

  32. Drewes AM, Svendsen L, Nielsen KD, Taagholt SJ, Bjerregård K. Quantification of alpha-EEG activity during sleep in fibromyalgia. J Musculoskelet Pain. 1994;2:33–53.

    Article  Google Scholar 

  33. Landis CA, Lentz MJ, Tsuji J, Buchwald D, Shaver JLF. Pain, psychological variables, sleep quality, and natural killer cell activity in midlife women with and without fibromyalgia. Brain Behav Immun. 2004;18:304–13.

    Article  PubMed  Google Scholar 

  34. Roizenblatt S, Moldofsky H, Benedito-Silva A, Tufik S. Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 2001;44.

    Google Scholar 

  35. Shaver JLF, Lentz M, Landis CA, Heitkemper M, Buchwald D, Woods N. Sleep, psychological distress, and stress arousal in women with fibromyalgia. Res Nurs Health. 1997;20

    Google Scholar 

  36. Besteiro González JL, Suárez Fernández TV, Arboleya Rodríguez L, Muñiz J, Lemos Giráldez S, Alvarez FA. Sleep architecture in patients with fibromyalgia. Psicothema. 2011;23:368–73.

    PubMed  Google Scholar 

  37. Roth T, Bhadra-Brown P, Pitman VW, Roehrs TA, Malca RE. Characteristics of disturbed sleep in patients with fibromyalgia compared with insomnia or with pain-free volunteers. Clin J Pain. 2016;32:302–7.

    Article  PubMed  Google Scholar 

  38. Burns JW, Crofford LJ, Chervin RD. Sleep stage dynamics in fibromyalgia patients and controls. Sleep Med. 2008;9:689–96.

    Article  PubMed  Google Scholar 

  39. Landis CA, Lentz MJ, Rothermel J, Buchwald D, Shaver JLF. Decreased sleep spindles and spindle activity in midlife women with fibromyalgia and pain. Sleep. 2004;27:741–50.

    Article  PubMed  Google Scholar 

  40. Pernambuco AP, Schetino LPL, Viana R de S, Carvalho L de SC, d’Ávila Reis D. The involvement of melatonin in the clinical status of patients with fibromyalgia syndrome. Clin Exp Rheumatol 2015;33:S14–S19.

    Google Scholar 

  41. Pivik RT, Harman K. A reconceptualization of EEG alpha activity as an index of arousal during sleep: all alpha activity is not equal. J Sleep Res. 1995;4:131–7.

    Article  CAS  PubMed  Google Scholar 

  42. Drewes AM, Nielsen KD, Jennum P, Andreasen A. Alpha intrusion in fibromyalgia. J Musculoskelet Pain. 1993;1:223–8.

    Article  Google Scholar 

  43. Chervin RD, Teodorescu M, Kushwaha R, Deline AM, Brucksch CB, Ribbens-Grimm C, Ruzicka DL, Stein PK, Clauw DJ, Crofford LJ. Objective measures of disordered sleep in fibromyalgia. J Rheumatol. 2009;36:2009–16.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Rosenfeld VW, Rutledge DN, Stern JM. Polysomnography with quantitative EEG in patients with and without fibromyalgia. J Clin Neurophysiol. 2015;32:164–70.

    Article  PubMed  Google Scholar 

  45. Yeung WK, Morgan K, Mckenna F. Comparison of sleep structure and psychometric profiles in patients with fibromyalgia, osteoarthritis and healthy controls. J Sleep Res. 2018;27:290–8.

    Article  PubMed  Google Scholar 

  46. Ulus Y, Akyol Y, Tander B, Durmus D, Bilgici A, Kuru O. Sleep quality in fibromyalgia and rheumatoid arthritis: associations with pain, fatigue, depression, and disease activity – PubMed. Clin Exp Rheumatol. 2011;29:S92–6.

    CAS  PubMed  Google Scholar 

  47. Roehrs T, Diederichs C, Gillis M, Burger AJ, Stout RA, Lumley MA, Roth T. Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary study. Sleep Med. 2013;14:109–15.

    Article  PubMed  Google Scholar 

  48. Terzano MG, Mancia D, Salati MR, Costani G, Decembrino A, Parrino L. The cyclic alternating pattern as a physiologic component of normal NREM sleep. Sleep. 1985;8:137–45.

    Article  CAS  PubMed  Google Scholar 

  49. Rizzi M, Sarzi-Puttini P, Atzeni F, Capsoni F, Andreoli A, Pecis M, Colombo S, Carrabba M, Sergi M. Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia? J Rheumatol. 2004;31:1193–9.

    PubMed  Google Scholar 

  50. Prados G, Miró E, Pilar Martínez M, Sánchez AI, López S, Sáez G. Fibromyalgia: gender differences and sleep-disordered breathing. Clin Exp Rheumatol. 2013;31:102–10.

    Google Scholar 

  51. Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-Chiong T, Loube DL, Owens J, Pancer JP, Wise M. Guideline update practice parameters for the indications for polysomnography and related procedures: an update for 2005. J Clin Sleep Med. 2017;13:479–504.

    Google Scholar 

  52. Civelek GM, Ciftkaya PO, Karatas M. Evaluation of restless legs syndrome in fibromyalgia syndrome: An analysis of quality of sleep and life. J Back Musculoskelet Rehabil. 2014;27:537–44.

    Article  PubMed  Google Scholar 

  53. Stehlik R, Arvidsson L, Ulfberg J. Restless legs syndrome is common among female patients with fibromyalgia. Eur Neurol. 2009;61:107–11.

    Article  PubMed  Google Scholar 

  54. Viola-Saltzman M, Watson NF, Bogart A, Goldberg J, Buchwald D. High prevalence of restless legs syndrome among patients with fibromyalgia: a controlled cross-sectional study. J Clin Sleep Med. 2010;6:423–7.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Parrino L, Halasz P, Tassinari CA, Terzano MG. CAP, epilepsy and motor events during sleep: the unifying role of arousal. Sleep Med Rev. 2006;10:267–85. https://pubmed.ncbi.nlm.nih.gov/16809057/ [Accessed November 27, 2020

    Article  PubMed  Google Scholar 

  56. Choy EHS. The role of sleep in pain and fibromyalgia. Nat Rev Rheumatol. 2015;11:513–20.

    Article  PubMed  Google Scholar 

  57. Pejovic S, Natelson BH, Basta M, Fernandez-Mendoza J, Mahr F, Vgontzas AN. Chronic fatigue syndrome and fibromyalgia in diagnosed sleep disorders: a further test of the “unitary” hypothesis. BMC Neurol. 2015;15

    Google Scholar 

  58. Moldofsky H, Scarisbrick P, England R, Smythe H. Musculosketal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med. 1975;37:341–51.

    Article  CAS  PubMed  Google Scholar 

  59. Smith MT, Edwards RR, McCann UD, Haythornthwaite JA. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep. 2007;30:494–505.

    Article  PubMed  Google Scholar 

  60. Mork PJ, Nilsen TIL. Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway. Arthritis Rheum. 2012;64:281–4.

    Article  PubMed  Google Scholar 

  61. Davies KA, Macfarlane GJ, Nicholl BI, Dickens C, Morriss R, Ray D, McBeth J. Restorative sleep predicts the resolution of chronic widespread pain: Results from the EPIFUND study. Rheumatology. 2008;47:1809–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Onen SH, Alloui A, Gross A, Eschallier A, Dubray C. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res. 2001;10:35–42.

    Article  CAS  PubMed  Google Scholar 

  63. Edwards RR, Almeida DM, Klick B, Haythornthwaite JA, Smith MT. Duration of sleep contributes to next-day pain report in the general population. Pain. 2008;137:202–7.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Wilson KG, Watson ST, Currie SR. Daily diary and ambulatory activity monitoring of sleep in patients with insomnia associated with chronic musculoskeletal pain. Pain. 1998;75:75–84.

    Article  PubMed  Google Scholar 

  65. Anderson RJ, McCrae CS, Staud R, Berry RB, Robinson ME. Predictors of clinical pain in fibromyalgia: examining the role of sleep. J Pain. 2012;13:350–8.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Haack M, Simpson N, Sethna N, Kaur S, Mullington J. Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications. Neuropsychopharmacology. 2020;45:205–16.

    Article  PubMed  Google Scholar 

  67. Monti JM. Serotonin control of sleep-wake behavior. Sleep Med Rev. 2011;15:269–81.

    Article  PubMed  Google Scholar 

  68. Murray NM, Buchanan GF, Richerson GB. Insomnia caused by serotonin depletion is due to hypothermia. Sleep. 2015;38:1985–93.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Meerlo P, Sgoifo A, Suchecki D. Restricted and disrupted sleep: effects on autonomic function, neuroendocrine stress systems and stress responsivity. Sleep Med Rev. 2008;12:197–210. https://pubmed.ncbi.nlm.nih.gov/18222099/ [Accessed December 4, 2020

    Article  PubMed  Google Scholar 

  70. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC. Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol. 1992;19:90–4.

    CAS  PubMed  Google Scholar 

  71. Baraniuk JN, Whalen G, Cunningham J, Clauw DJ. Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord. 2004;5:48.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  72. Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta J-K. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci. 2007;27:10000–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Trofimovitch D, Baumrucker SJ. Pharmacology update: low-dose naltrexone as a possible nonopioid modality for some chronic, nonmalignant pain syndromes. Am J Hosp Palliat Care. 2019;36:907–12.

    Article  PubMed  Google Scholar 

  74. Curtis AF, Miller MB, Rathinakumar H, Robinson M, Staud R, Berry RB, McCrae CS. Opioid use, pain intensity, age, and sleep architecture in patients with fibromyalgia and insomnia. Pain. 2019;160:2086–92.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Darnall BD, Stacey BR, Chou R. Medical and psychological risks and consequences of long-term opioid therapy in women. Pain Med (United States). 2012;13:1181–1211.

    Google Scholar 

  76. Liu Z, Welin M, Bragee B, Thörnwall M, Nyberg F. Elevated substance P level in cerebrospinal fluid from patients with fibromyalgia is contrasted by a decrease in met-enkephalin-arg-phe. Analgesia. 1995;1:543–7.

    Article  Google Scholar 

  77. Andersen ML, Nascimento DC, MacHado RB, Roizenblatt S, Moldofsky H, Tufik S. Sleep disturbance induced by substance P in mice. Behav Brain Res. 2006;167:212–8.

    Article  CAS  PubMed  Google Scholar 

  78. Zhang G, Wang L, Liu H, Zhang J. Substance P promotes sleep in the ventrolateral preoptic area of rats. Brain Res. 2004;1028:225–32.

    Article  CAS  PubMed  Google Scholar 

  79. Lieb K, Ahlvers K, Dancker K, Strohbusch S, Reincke M, Feige B, Berger M, Riemann D, Voderholzer U. Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men. Neuropsychopharmacology. 2002;27:1041–9.

    Article  CAS  PubMed  Google Scholar 

  80. Ursavas A, Karadag M, Ilcol YO, Burgazlioglu B, Ercan I, Gozu RO. Relationship between serum substance P levels and daytime sleepiness in obstructive sleep apnea syndrome. Chest. 2007;131:1400–5.

    Article  CAS  PubMed  Google Scholar 

  81. Veldhuis JD, Iranmanesh A. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep. In: Sleep. Vol 19. Associated Professional Sleep Societies,LLC; 1996.

    Google Scholar 

  82. Bennett RM. Adult growth hormone deficiency in patients with fibromyalgia. Curr Rheumatol Rep. 2002;4:306–12. https://pubmed.ncbi.nlm.nih.gov/12126582/ [Accessed December 4, 2020

    Article  PubMed  Google Scholar 

  83. Cuatrecasas G, Alegre C, Casanueva FF. GH/IGF1 axis disturbances in the fibromyalgia syndrome: Is there a rationale for GH treatment? Pituitary. 2014;17:277–83.

    Article  CAS  PubMed  Google Scholar 

  84. Hayta E, Okşaşoğlu AA. Decrease of serum IGF-1 level is not associated with obstructive sleep apnea in fibromyalgia patients. Arch Rheumatol. 2017;32:105–11.

    Article  PubMed  Google Scholar 

  85. Dias RCA, Kulak Junior J, Ferreira da Costa EH, Nisihara RM. Fibromyalgia, sleep disturbance and menopause: Is there a relationship? A literature review. Int J Rheum Dis. 2019;22:1961–71.

    Article  PubMed  Google Scholar 

  86. van Dalfsen JH, Markus CR. The influence of sleep on human hypothalamic–pituitary–adrenal (HPA) axis reactivity: a systematic review. Sleep Med Rev. 2018;39:187–94.

    Article  PubMed  Google Scholar 

  87. Goodin BR, Smith MT, Quinn NB, King CD, McGuire L. Poor sleep quality and exaggerated salivary cortisol reactivity to the cold pressor task predict greater acute pain severity in a non-clinical sample. Biol Psychol. 2012;91:36–41.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Borchers AT, Gershwin ME. Fibromyalgia: a critical and comprehensive review. Clin Rev Allergy Immunol. 2015;49:100–51.

    Article  CAS  PubMed  Google Scholar 

  89. Casale R, Sarzi-Puttini P, Botto R, Alciati A, Batticciotto A, Marotto D, Torta R. Fibromyalgia and the concept of resilience. Clin Exp Rheumatol. 2019;37:105–13.

    PubMed  Google Scholar 

  90. Furlan R, Colombo S, Perego F, Atzeni F, Diana A, Barbic F, Porta A, Pace F, Malliani A, Sarzi-Puttini P. Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J Rheumatol. 2005;32:1787–93.

    PubMed  Google Scholar 

  91. Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: The most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17:241–254. Available at: /pmc/articles/PMC3672328/?report=abstract [Accessed December 4, 2020].

    Google Scholar 

  92. Kondo H, Ozone M, Ohki N, Sagawa Y, Yamamichi K, Fukuju M, Yoshida T, Nishi C, Kawasaki A, Mori K, Kanbayashi T, Izumi M, Hishikawa Y, Nishino S, Shimizu T. Association between heart rate variability, blood pressure and autonomic activity in cyclic alternating pattern during sleep. Sleep. 2014;37:187–94.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Mork PJ, Nilsson J, Lorås HW, Riva R, Lundberg U, Westgaard RH. Heart rate variability in fibromyalgia patients and healthy controls during non-REM and REM sleep: a case-control study. Scand J Rheumatol. 2013;42:505–8.

    Article  CAS  PubMed  Google Scholar 

  94. Rizzi M, Radovanovic D, Santus P, Airoldi A, Frassanito F, Vanni S, Cristiano A, Masala IF, Sarzi-Puttini P. Influence of autonomic nervous system dysfunction in the genesis of sleep disorders in fibromyalgia patients. Clin Exp Rheumatol. 2017;35:74–80.

    PubMed  Google Scholar 

  95. Rizzi M, Sarzi-puttini P, Giorgi V, Radovanovic D, Pini S, Gaboardi P, Santus P. Correlations between sleep disturbances and pain in fibromyalgia: an updated review. Chronic Pain Manag. 2020;4.

    Google Scholar 

  96. Ryabkova VA, Churilov LP, Shoenfeld Y. Neuroimmunology: what role for autoimmunity, neuroinflammation, and small fiber neuropathy in fibromyalgia, chronic fatigue syndrome, and adverse events after human papillomavirus vaccination? Int J Mol Sci. 2019;20

    Google Scholar 

  97. Toussaint LL, Vincent A, McAllister SJ, Oh TH, Hassett AL. A comparison of fibromyalgia symptoms in patients with Healthy versus Depressive, Low and Reactive affect balance styles. Scand J Pain. 2014;5:161–6.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Geisser ME, Casey KL, Brucksch CB, Ribbens CM, Appleton BB, Crofford LJ. Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. Pain. 2003;102:243–50.

    Article  PubMed  Google Scholar 

  99. Sivertsen B, Harvey AG, Pallesen S, Hysing M. Mental health problems in adolescents with delayed sleep phase: results from a large population-based study in Norway. J Sleep Res. 2015;24:11–8.

    Article  PubMed  Google Scholar 

  100. Palagini L, Carmassi C, Conversano C, Gesi C, Bazzichi L, Giacomelli C, Dell’osso L. Transdiagnostic factors across fibromyalgia and mental disorders: sleep disturbances may play a key role. A clinical review. Clin Exp Rheumatol. 2016;34:140–4.

    Google Scholar 

  101. Türkoğlu G, Selvi Y. The relationship between chronotype, sleep disturbance, severity of fibromyalgia, and quality of life in patients with fibromyalgia. Chronobiol Int. 2020;37:68–81.

    Article  PubMed  Google Scholar 

  102. Yazdi Z, Loukzadeh Z, Moghaddam P, Jalilolghadr S. Sleep hygiene practices and their relation to sleep quality in medical students of Qazvin University of Medical Sciences. J Caring Sci. 2016;5:153–60.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Bernardy K, Klose P, Welsch P, Häuser W. Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome – a systematic review and meta-analysis of randomized controlled trials. Eur J Pain. 2018;22:242–60.

    Article  CAS  PubMed  Google Scholar 

  104. Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Longley K, Mccarthy GM, Makri S, Perrot S, Taylor A, Jones GT. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76:318–28.

    Article  CAS  PubMed  Google Scholar 

  105. Uchida S, Shioda K, Morita Y, Kubota C, Ganeko M, Takeda N. Exercise effects on sleep physiology. Front Neurol. 2012;3:1–5.

    Article  Google Scholar 

  106. Roth T, Bhadra-Brown P, Pitman VW, Malca RE. Pregabalin improves fibromyalgia-related sleep disturbance. Clin J Pain. 2016;32:308–12.

    Article  PubMed  Google Scholar 

  107. Pauer L, Winkelmann A, Arsenault P, Jespersen A, Whelan L, Atkinson G, Leon T, Zeiher B. An international, randomized, double-blind, placebo-controlled,phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia. J Rheumatol. 2011;38:2643–52.

    Article  CAS  PubMed  Google Scholar 

  108. Cooper TE, Derry S, Wiffen PJ, Moore RA. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst Rev. 2017;2017

    Google Scholar 

  109. North JM, Hong K, Soo J, Rauck RL. The effect of a novel form of extended-release gabapentin on pain and sleep in fibromyalgia subjects: an open-label pilot study. Pain Pract. 2016;16:720–9.

    Article  PubMed  Google Scholar 

  110. Häuser W, Urrútia G, Tort S, Üçeyler N, Walitt B. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev. 2013:CD010292.

    Google Scholar 

  111. Choy EH. Current treatments to counter sleep dysfunction as a pathogenic stimulus of fibromyalgia. Pain Manag. 2016;6:339–46.

    Article  PubMed  Google Scholar 

  112. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database Syst Rev. 2015;2017. Available at: /pmc/articles/PMC6485478/?report=abstract [Accessed December 4, 2020].

    Google Scholar 

  113. Wichniak A, Wierzbicka A, Walęcka M, Jernajczyk W. Effects of antidepressants on sleep. Curr Psychiatry Rep. 2017;19. Available at: /pmc/articles/PMC5548844/?report=abstract [Accessed December 4, 2020].

    Google Scholar 

  114. Moldofsky H, Lue FA, Mously C, Roth-Schechter B, Reynolds WJ. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol. 1996;23:529–33.

    CAS  PubMed  Google Scholar 

  115. Tofferi JK, Jackson JL, O’Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 2004;51:9–13.

    Article  CAS  PubMed  Google Scholar 

  116. Moldofsky H, Harris HW, Tad Archambault W, Kwong T, Lederman S. Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: A double-blind randomized placebo-controlled study. J Rheumatol. 2011;38:2653–63.

    Article  CAS  PubMed  Google Scholar 

  117. Spaeth M, Bennett RM, Benson BA, Wang YG, Lai C, Choy EH. Sodium oxybate therapy provides multidimensional improvement in fi bromyalgia: results of an international phase 3 trial. Ann Rheum Dis. 2012;71:935–42.

    Article  CAS  PubMed  Google Scholar 

  118. Staud R. Sodium oxybate for the treatment of fibromyalgia. Expert Opin Pharmacother. 2011;12:1789–98.

    Article  CAS  PubMed  Google Scholar 

  119. Spaeth M, Alegre C, Perrot S, Wang YG, Guinta DR, Alvarez-Horine S, Russell IJ. Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia. Arthritis Res Ther. 2013;15:1–13.

    Article  CAS  Google Scholar 

  120. Citera G, Arias MA, Maldonado-Cocco JA, Lázaro MA, Rosemffet MG, Brusco LI, Scheines EJ, Cardinalli DP. The effect of melatonin in patients with fibromyalgia: A pilot study. Clin Rheumatol. 2000;19:9–13.

    Article  CAS  PubMed  Google Scholar 

  121. de Zanette SA, Vercelino R, Laste G, Rozisky JR, Schwertner A, Machado CB, Xavier F, de Souza ICC, Deitos A, Torres ILS, Caumo W. Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial. BMC Pharmacol Toxicol. 2014;15:40.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  122. Gates PJ, Albertella L, Copeland J. The effects of cannabinoid administration on sleep: a systematic review of human studies. Sleep Med Rev. 2014;18:477–87.

    Article  PubMed  Google Scholar 

  123. Walitt B, Klose P, Ma F, Phillips T, Häuser W. Cannabinoids for fibromyalgia (Review). Cochrane Database Syst Rev. 2016;

    Google Scholar 

  124. Ware MA, Fitzcharles M-A, Joseph L, Shir Y. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg. 2010;110:604–10.

    Article  CAS  PubMed  Google Scholar 

  125. Hill KP, Palastro MD, Johnson B, Ditre JW. Cannabis and pain: a clinical review. Cannabis Cannabinoid Res. 2017;2:96–104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, Ko G, Moulin DE, Panopalis P, Proulx J, Shir Y. 2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: Executive summary. Pain Res Manag. 2013;18:119–126. Available at: /pmc/articles/PMC3673928/?report=abstract [Accessed December 4, 2020].

    Google Scholar 

  127. The National Academies of Science Engineering and Medicine. The health effects of cannabis and cannabinoids. committee’s conclusions. 2017.

    Google Scholar 

  128. Giorgi V, Bongiovanni S, Atzeni F, Marotto D, Salaffi F, Sarzi-Puttini P. Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study. Clin Exp Rheumatol. 2020;38:53–9.

    PubMed  Google Scholar 

  129. Sagy I, Bar-Lev Schleider L, Abu-Shakra M, Novack V. Safety and efficacy of medical cannabis in fibromyalgia. J Clin Med. 2019;8:807.

    Article  CAS  PubMed Central  Google Scholar 

  130. National Pain Report. Marijuana rated most effective for treating fibromyalgia. Natl Pain Rep. 2014.

    Google Scholar 

  131. Bennett R. Fibromyalgia: shining a light on fibromyalgia treatment. Nat Rev Rheumatol. 2016;12:568–9.

    Article  PubMed  Google Scholar 

  132. Arnold LM, Emir B, Pauer L, Resnick M, Clair A. Time to improvement of pain and sleep quality in clinical trials of pregabalin for the treatment of fibromyalgia. Pain Med (United States). 2015;16:176–185.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology Unit, ASST-Fatebenefratelli “Luigi Sacco” University Hospital, Milan, Italy

    Valeria Giorgi, Maurizio Rizzi & Piercarlo Sarzi-Puttini

  2. Rheumatology Unit, Internal Medicine Department ASST Settelaghi, Ospedale Di Circolo – Fondazione Macchi, Varese, Italy

    Alberto Batticciotto

Authors
  1. Valeria Giorgi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alberto Batticciotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maurizio Rizzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Piercarlo Sarzi-Puttini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Valeria Giorgi .

Editor information

Editors and Affiliations

  1. Tel Aviv Sourasky Medical Center & Tel Aviv University School of Medicine, Tel Aviv, Israel

    Jacob N. Ablin

  2. Ariel University, Ariel, Israel

    Yehuda Shoenfeld

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Giorgi, V., Batticciotto, A., Rizzi, M., Sarzi-Puttini, P. (2021). Fibromyalgia Syndrome and Sleep. In: Ablin, J.N., Shoenfeld, Y. (eds) Fibromyalgia Syndrome . Springer, Cham. https://doi.org/10.1007/978-3-030-78638-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-78638-0_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-78637-3

  • Online ISBN: 978-3-030-78638-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation